Fmr LLC Grows Stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Fmr LLC increased its holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 29.4% during the third quarter, HoldingsChannel reports. The institutional investor owned 1,057 shares of the company’s stock after acquiring an additional 240 shares during the quarter. Fmr LLC’s holdings in Invesco Pharmaceuticals ETF were worth $92,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in PJP. Howe & Rusling Inc. bought a new stake in Invesco Pharmaceuticals ETF during the third quarter valued at approximately $48,000. International Assets Investment Management LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 2nd quarter worth $66,000. Secure Asset Management LLC purchased a new position in Invesco Pharmaceuticals ETF in the third quarter worth $229,000. &PARTNERS bought a new position in Invesco Pharmaceuticals ETF in the second quarter valued at $308,000. Finally, HBW Advisory Services LLC purchased a new stake in Invesco Pharmaceuticals ETF during the third quarter valued at about $509,000.

Invesco Pharmaceuticals ETF Trading Up 0.6 %

PJP opened at $83.16 on Tuesday. The stock has a market capitalization of $281.91 million, a P/E ratio of 21.48 and a beta of 0.61. The stock has a 50-day moving average price of $86.32 and a 200-day moving average price of $85.47. Invesco Pharmaceuticals ETF has a 12-month low of $74.82 and a 12-month high of $89.87.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.